{"success":true,"data":{"pressRelease":{"id":"162915","rtpr_id":"nPn5s6Bzra-20261007","ticker":"QDEL","exchange":"NASDAQ","all_tickers":["QDEL"],"title":"QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations","author":"PR Newswire","published_at":"2026-10-07T11:13:00.030Z","article_body":"QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations\nPR Newswire\n\nSAN DIEGO, Oct. 7, 2026\n\nSAN DIEGO, Oct. 7, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq:\nQDEL) (\"QuidelOrtho\"), a leading global provider of diagnostic solutions, has\nappointed Sanjeev Sharma, CFA, as Vice President, Investor Relations,\neffective September 28, 2026.\n\nMr. Sharma brings more than 20 years of experience across investor relations,\ncorporate strategy and equity research at global organizations. Most recently,\nhe served as Senior Director of Investor Relations at Teva Pharmaceuticals,\nwhere he closely partnered with senior leadership to communicate the company's\nstrategy and strengthen engagement with the investment community during a\nperiod of significant transformation. Previously, he spent more than a decade\nat Genpact in progressively senior roles across investor relations and\nbusiness strategy. Earlier in his career, he spent nearly six years in\nsell-side equity research. Mr. Sharma holds a master's degree in finance and\nis a Chartered Financial Analyst (CFA).\n\n\"We are pleased to welcome Sanjeev to QuidelOrtho,\" said Micah Young, Chief\nFinancial Officer of QuidelOrtho. \"He brings a valuable combination of\ninvestor relations leadership, healthcare experience, financial expertise and\ncapital markets perspective. Sanjeev's experience partnering with executive\nteams and translating strategy and performance into a clear investor narrative\nwill be especially valuable as we sharpen our communications and deepen our\nengagement with shareholders and analysts.\"\n\nMr. Sharma added, \"I am excited to join QuidelOrtho at this important stage in\nthe company's journey. QuidelOrtho plays a vital role in advancing healthcare\naround the world. I look forward to partnering with the leadership team to\ndeepen engagement with the investment community and communicate the company's\nstrategic priorities and progress focused on long-term value creation.\"\n\nQuidelOrtho is dedicated to advancing diagnostics to power a healthier future.\nFor more information, please visit quidelortho.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4791375-1&h=1322104871&u=http%3A%2F%2Fwww.quidelortho.com%2F&a=quidelortho.com)\n and follow QuidelOrtho on LinkedIn, Facebook and X.\n\nAbout QuidelOrtho Corporation\nWith expertise spanning clinical chemistry, immunoassay, immunohematology and\nmolecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global\nprovider of diagnostic solutions, dedicated to advancing fast, accurate and\nreliable results that help improve patient outcomes – from the point of care\nto hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho\nworks with healthcare providers to advance diagnostics that connect insights\nwith solutions, defining a clearer path for informed decisions and better\ncare.\n\nInvestor Contact:\nSanjeev Sharma\nVice President, Investor Relations\nIR@QuidelOrtho.com (mailto:IR@QuidelOrtho.com)\n\nMedia Contact:\nStephanie Kleewein\nSenior Corporate Communication and PR Manager\nmedia@QuidelOrtho.com (mailto:media@QuidelOrtho.com)\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/quidelortho-appoints-sanjeev-sharma-as-vice-president-of-investor-relations-302900416.html\n(https://www.prnewswire.com/news-releases/quidelortho-appoints-sanjeev-sharma-as-vice-president-of-investor-relations-302900416.html)\n\nSOURCE QuidelOrtho Corporation\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS2003869/Sanjeev_Sharma_Headshot.jpg?id=OA2991309\nhttps://mmx.prnewswire.com/media/MS1766215/QuidelOrtho-Logo.jpg?id=OA2991306\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn5s6Bzra-20261007","title":"QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations","author":"PR Newswire","ticker":"QDEL","created":"2026-10-07T11:13:00.030Z","tickers":["QDEL"],"exchange":"NASDAQ","article_body":"QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations\nPR Newswire\n\nSAN DIEGO, Oct. 7, 2026\n\nSAN DIEGO, Oct. 7, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq:\nQDEL) (\"QuidelOrtho\"), a leading global provider of diagnostic solutions, has\nappointed Sanjeev Sharma, CFA, as Vice President, Investor Relations,\neffective September 28, 2026.\n\nMr. Sharma brings more than 20 years of experience across investor relations,\ncorporate strategy and equity research at global organizations. Most recently,\nhe served as Senior Director of Investor Relations at Teva Pharmaceuticals,\nwhere he closely partnered with senior leadership to communicate the company's\nstrategy and strengthen engagement with the investment community during a\nperiod of significant transformation. Previously, he spent more than a decade\nat Genpact in progressively senior roles across investor relations and\nbusiness strategy. Earlier in his career, he spent nearly six years in\nsell-side equity research. Mr. Sharma holds a master's degree in finance and\nis a Chartered Financial Analyst (CFA).\n\n\"We are pleased to welcome Sanjeev to QuidelOrtho,\" said Micah Young, Chief\nFinancial Officer of QuidelOrtho. \"He brings a valuable combination of\ninvestor relations leadership, healthcare experience, financial expertise and\ncapital markets perspective. Sanjeev's experience partnering with executive\nteams and translating strategy and performance into a clear investor narrative\nwill be especially valuable as we sharpen our communications and deepen our\nengagement with shareholders and analysts.\"\n\nMr. Sharma added, \"I am excited to join QuidelOrtho at this important stage in\nthe company's journey. QuidelOrtho plays a vital role in advancing healthcare\naround the world. I look forward to partnering with the leadership team to\ndeepen engagement with the investment community and communicate the company's\nstrategic priorities and progress focused on long-term value creation.\"\n\nQuidelOrtho is dedicated to advancing diagnostics to power a healthier future.\nFor more information, please visit quidelortho.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4791375-1&h=1322104871&u=http%3A%2F%2Fwww.quidelortho.com%2F&a=quidelortho.com)\n and follow QuidelOrtho on LinkedIn, Facebook and X.\n\nAbout QuidelOrtho Corporation\nWith expertise spanning clinical chemistry, immunoassay, immunohematology and\nmolecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global\nprovider of diagnostic solutions, dedicated to advancing fast, accurate and\nreliable results that help improve patient outcomes – from the point of care\nto hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho\nworks with healthcare providers to advance diagnostics that connect insights\nwith solutions, defining a clearer path for informed decisions and better\ncare.\n\nInvestor Contact:\nSanjeev Sharma\nVice President, Investor Relations\nIR@QuidelOrtho.com (mailto:IR@QuidelOrtho.com)\n\nMedia Contact:\nStephanie Kleewein\nSenior Corporate Communication and PR Manager\nmedia@QuidelOrtho.com (mailto:media@QuidelOrtho.com)\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/quidelortho-appoints-sanjeev-sharma-as-vice-president-of-investor-relations-302900416.html\n(https://www.prnewswire.com/news-releases/quidelortho-appoints-sanjeev-sharma-as-vice-president-of-investor-relations-302900416.html)\n\nSOURCE QuidelOrtho Corporation\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS2003869/Sanjeev_Sharma_Headshot.jpg?id=OA2991309\nhttps://mmx.prnewswire.com/media/MS1766215/QuidelOrtho-Logo.jpg?id=OA2991306\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-10-07T11:13:00.06697189Z","server_sent_at_ms":1791371580066},"received_at":"2026-10-07T11:13:00.118Z","source_url":"https://www.prnewswire.com/news-releases/quidelortho-appoints-sanjeev-sharma-as-vice-president-of-investor-relations-302900416.html"},"analysis":{"id":"151386","press_release_id":"162915","analysis_json":{"industry":{"label":"Health Care Equipment & Supplies","sector":"Health Care"},"redFlags":[],"eventType":"executive_change","narrative":"QuidelOrtho appointed Sanjeev Sharma, CFA, as Vice President of Investor Relations, effective September 28, 2026.\n\nSharma brings 20+ years of experience, most recently as Senior Director of IR at Teva Pharmaceuticals, with prior IR and strategy roles at Genpact and sell-side equity research experience.\n\nThis is a routine IR leadership appointment with no change to CFO or other executive officers and no financial implications disclosed.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine IR head appointment -- suppress unless tracking management changes."},"keyFigures":{},"quotedText":"He brings a valuable combination of investor relations leadership, healthcare experience, financial expertise and capital markets perspective.","namedEntities":{"people":[{"name":"Sanjeev Sharma","role":"Vice President, Investor Relations (newly appointed)"},{"name":"Micah Young","role":"CFO"}],"products":[],"companies":[{"name":"QuidelOrtho Corporation","ticker":"QDEL","relationship":"filer"},{"name":"Teva Pharmaceuticals","relationship":"new hire's prior employer"},{"name":"Genpact","relationship":"new hire's prior employer"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Appointment of a VP-level Investor Relations head is a routine, non-executive-officer personnel announcement with no financial or strategic impact."},"tickerRelevance":{"others":[],"primary":"QDEL"},"globalImportance":5,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"VP-level IR appointment","executiveOfficerChange":false}},"event_type":"executive_change","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"QuidelOrtho appointed Sanjeev Sharma, CFA, as Vice President of Investor Relations, effective September 28, 2026.\n\nSharma brings 20+ years of experience, most recently as Senior Director of IR at Teva Pharmaceuticals, with prior IR and strategy roles at Genpact and sell-side equity research experience.\n\nThis is a routine IR leadership appointment with no change to CFO or other executive officers and no financial implications disclosed.","key_figures":{},"named_entities":{"people":[{"name":"Sanjeev Sharma","role":"Vice President, Investor Relations (newly appointed)"},{"name":"Micah Young","role":"CFO"}],"products":[],"companies":[{"name":"QuidelOrtho Corporation","ticker":"QDEL","relationship":"filer"},{"name":"Teva Pharmaceuticals","relationship":"new hire's prior employer"},{"name":"Genpact","relationship":"new hire's prior employer"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-07T11:13:04.380Z","global_importance":5,"audience_relevance":10,"importance_components":{"tickerTier":"mid-cap","eventGravity":"VP-level IR appointment","executiveOfficerChange":false}},"durationMs":4252,"modelName":"glm-5.3-flashx"}}